1. Home
  2. KVYO vs INDV Comparison

KVYO vs INDV Comparison

Compare KVYO & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

N/A

Current Price

$17.85

Market Cap

5.3B

Sector

N/A

ML Signal

N/A

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$40.01

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVYO
INDV
Founded
2012
N/A
Country
United States
United States
Employees
N/A
838
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
4.7B
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
KVYO
INDV
Price
$17.85
$40.01
Analyst Decision
Strong Buy
Analyst Count
21
0
Target Price
$34.48
N/A
AVG Volume (30 Days)
3.4M
1.4M
Earning Date
05-05-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
8100.00
EPS
0.03
0.69
Revenue
$1,234,019,000.00
$1,239,000,000.00
Revenue This Year
$24.47
N/A
Revenue Next Year
$19.66
N/A
P/E Ratio
$611.67
$58.19
Revenue Growth
31.63
4.29
52 Week Low
$12.53
$20.67
52 Week High
$36.76
$42.81

Technical Indicators

Market Signals
Indicator
KVYO
INDV
Relative Strength Index (RSI) 57.52 44.88
Support Level $17.48 $38.47
Resistance Level $18.54 $41.42
Average True Range (ATR) 1.09 1.36
MACD 0.09 -0.20
Stochastic Oscillator 63.39 21.01

Price Performance

Historical Comparison
KVYO
INDV

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: